Source: WRAL TECHWIRE, 10/27/20

 Asklepios BioPharmaceutical (AskBio), a pioneering gene therapy company born in Chapel Hill 19 years ago and supported in its early years by the North Carolina Biotechnology Center, will be acquired by Bayer AG, the German healthcare and agriculture conglomerate, for up to $4 billion. The acquisition is the third largest buyout of a home-grown North Carolina bioscience company, trailing Salix’s acquisition by Valeant in 2015 for $11 billion and Quintiles’...

For more of this story, click here.